HIPEC Cancer Surgery in India for Omanis: A Doctor’s Guide to Making the Right Decision

Author:- Dr. Dheeraj Bojwani Date Created:- 06-08-2026

HIPEC — hyperthermic intraperitoneal chemotherapy — is among the most demanding procedures in cancer surgery, and also one of the most effective options available for a specific, difficult category of disease: cancer that has spread across the lining of the abdominal cavity. For Omani patients facing this diagnosis, often after standard chemotherapy alone has not controlled the disease, understanding exactly what this procedure involves matters enormously. Over 24 years of guiding Gulf families through complex cancer decisions, I want to walk you through this honestly. Oman's hospitals, including Apollo Hospital Muscat, Badr Al Samaa, Aster Al Raffah, and Burjeel Medical Centre, provide oncology consultation, though HIPEC itself is a highly specialised procedure not widely available across the region. This guide is written to help Omani patients understand what HIPEC actually involves, when it is genuinely appropriate, and what to check carefully before travelling for it.

Healing Journeys of Omani Patients

Omani Patients Share Their Experience

Understanding What HIPEC Actually Involves

HIPEC is not a standalone treatment but the second half of a two-part procedure. First comes cytoreductive surgery, where a surgeon works to remove every visible trace of tumour from the abdominal cavity — sometimes requiring removal of parts of the bowel, spleen, gallbladder, or the peritoneal lining itself, depending on how far the disease has spread. Immediately afterward, heated chemotherapy, warmed to around 41 to 43 degrees Celsius, is circulated directly through the abdominal cavity for 60 to 90 minutes, targeting microscopic cancer cells the surgeon's eye could not see. The heat itself enhances the chemotherapy's effectiveness, and delivering it directly into the abdomen allows much higher local doses than would be safe given through the bloodstream.

This is a genuinely major operation, often lasting eight to fourteen hours, and candidacy is far from automatic. Surgeons use a Peritoneal Cancer Index, a scoring system that measures how extensively the disease has spread across the abdominal cavity, to help determine whether complete tumour removal is realistically achievable. Patients with very high scores, meaning very extensive disease, may not be good candidates, since the procedure's benefit depends heavily on achieving a genuinely complete cytoreduction. This is precisely why proper patient selection, not eagerness to operate, is the most important factor in a good HIPEC outcome.

What Makes India a Strong Option for HIPEC Surgery

India's leading surgical oncology centres, particularly in Delhi, Mumbai, Chennai, and Bengaluru, have built genuine, high-volume expertise in cytoreductive surgery and HIPEC for peritoneal disease arising from colorectal, appendiceal, ovarian, and gastric cancers, alongside primary peritoneal malignancies. This volume matters enormously for HIPEC specifically, since outcomes are closely tied to how experienced a specific surgical team is with achieving complete cytoreduction and managing the intensive perioperative care this procedure demands.

India also gives patients access to dedicated peritoneal surface malignancy programmes with surgical oncologists specifically trained in this technique, supported by intensive care teams experienced in managing the demanding recovery period that follows. And because Indian hospitals have spent two decades building international oncology pathways for Gulf and African patients, Omani patients arrive to Arabic-speaking coordinators and a well-tested process for reviewing imaging and pathology before travel is even booked.

Given how specialised and resource-intensive this procedure is worldwide, the practical question for most Omani patients is less about comparing many regional options and more about finding a centre with genuine, specific, high-volume HIPEC experience — something India's leading peritoneal malignancy programmes offer at a fraction of Western cost.

Cost Comparison: India vs. Oman/Regional vs. Western Countries

The figures below represent a combined cytoreductive surgery and HIPEC package, in approximate US dollars, for a full package at an accredited private hospital. Peer-reviewed research on institutional direct costs in the United States has found this procedure carries substantial resource use even before broader hospital charges are added.

What a Typical Omani Patient Should Weigh Before Deciding HIPEC Surgery in India

Having guided patients through this exact decision for 24 years, here is what I encourage every Omani family to work through before committing to a hospital:

1. Get an honest assessment of your Peritoneal Cancer Index score. Send your imaging to an independent peritoneal malignancy specialist in India before committing. A responsible team will tell you plainly whether complete cytoreduction is realistically achievable for your specific disease extent.
2. Ask which chemotherapy agent is planned for the heated perfusion. Mitomycin C, cisplatin, and oxaliplatin are used for different tumour types and profiles. Understand why a specific drug is being recommended for you.
3. Get the full package itemised in writing. Surgery, ICU days, chemotherapy drugs, and follow-up should each be clear, along with what additional organ resection would add to the cost if the surgeon finds more extensive disease than expected.
4. Check your insurance and Ministry of Health position. Some Omani insurance plans and employer health schemes offer partial reimbursement for treatment abroad; others do not cover it at all. Clarify this before you travel, not after.
5. Ask specifically about the surgeon's HIPEC-specific case volume. This is one of the most technically demanding procedures in oncology. Ask how many CRS/HIPEC procedures the specific surgeon and team perform each year.
6. Plan for a genuinely demanding recovery period. This surgery typically requires a longer hospital stay and more intensive support at home than most other cancer procedures. Arrange this support in Oman well in advance.

A Closing Reflection

HIPEC represents genuine hope for patients facing a category of cancer spread that once offered very limited options, but it asks a great deal in return — a long, complex operation and a recovery that tests both patient and family. The single factor that separates a genuinely beneficial outcome from a difficult one without meaningful gain is careful, honest patient selection before surgery ever begins. That honesty is worth insisting on, wherever the operation ultimately takes place. An independent, imaging-based assessment of whether complete cytoreduction is realistically achievable in your case is the most important conversation to have before any decision is made.

Sources & Further Reading

• National Cancer Institute (NCI), National Institutes of Health — Hyperthermic Intraperitoneal Chemotherapy (cancer.gov)
• MedlinePlus, U.S. National Library of Medicine (NIH) — Peritoneal Cancer (medlineplus.gov)
• American Cancer Society (ACS), non-profit organization — Intraperitoneal Chemotherapy (cancer.org)
• PubMed, National Library of Medicine (NIH) — What Drives High Costs of Cytoreductive Surgery and HIPEC (pubmed.ncbi.nlm.nih.gov)
• Society of Surgical Oncology (SSO), non-profit professional association — Patient Resources (surgonc.org)

Frequently Asked Questions by Omani Patients about HIPEC Cancer Surgery in India